Similar articles

• Molecular landscape of pancreatic cancer: challenges and clinical implications.

  Kyrochristos ID, Ziogas DE, Glantzounis GK, Roukos DH. Kyrochristos ID, et al. Future Oncol. 2017 Dec;13(30):2741-2744. doi: 10.2217/fon-2017-0335. Epub 2017 Nov 28. Future Oncol. 2017. PMID: 29182377 No abstract available.
• The need for effective pancreatic cancer detection and management: a biomarker-based strategy.

  Crawley AS, O'Kennedy RJ. Crawley AS, et al. Expert Rev Mol Diagn. 2015;15(10):1339-53. doi: 10.1586/14737159.2015.1083862. Expert Rev Mol Diagn. 2015. PMID: 26394703 Review.
• MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?

  Mardin WA, Mees ST. Mardin WA, et al. Ann Surg Oncol. 2009 Nov;16(11):3183-9. doi: 10.1245/s10434-009-0623-1. Epub 2009 Jul 28. Ann Surg Oncol. 2009. PMID: 19636633 Review.
• The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms.

  ASGE Standards of Practice Committee; Muthusamy VR, Chandrasekhara V, Acosta RD, Bruining DH, Chathadi KV, Eloubeidi MA, Faulx AL, Fonkalsrud L, Gurudu SR, Khashab MA, Kothari S, Lightdale JR, Pasha SF, Saltzman JR, Shaukat A, Wang A, Yang J, Cash BD, DeWitt JM. ASGE Standards of Practice Committee, et al. Gastrointest Endosc. 2016 Jul;84(1):1-9. doi: 10.1016/j.gie.2016.04.014. Epub 2016 May 17. Gastrointest Endosc. 2016. PMID: 27206409 No abstract available.
• Molecular subtypes of pancreatic cancer.

  Collisson EA, Bailey P, Chang DK, Biankin AV. Collisson EA, et al. Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):207-220. doi: 10.1038/s41575-019-0109-y. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30718832 Review.